Overall, the studies analyzed in this systematic review consistently highlight the translational potential of touchscreen platforms for cognitive assessment across human and rodent models in conditions such as DLG2 CNV deletions, OCD, HD, stroke and pharmacological intervention. This evidence concerns the gene DLG2 and Huntington disease.